GalaXi — navigating the WuXi virtual space

webinar

Wed, 18 Dec 2019, 18:00 CET (Berlin)

Dr. Carl Kaub, WuXi LabNetwork, Cambridge, Massachusetts, United States

GalaXi — navigating the WuXi virtual space

As drug discovery researchers seek chemical matter, in silico techniques are increasingly utilized to broaden the field of potential leads. At the same time, accessing virtually enumerated compound data can be problematic due to high data volumes and traditionally unreliable synthetic viability.

In this discussion we will review the background chemistry and building block foundations of WuXi AppTec’s virtual library along with the new GalaXi chemical space. GalaXi is a new platform that enables exceptionally fast searches against WuXi’s 1.8 billion virtual compounds and returns results within seconds to minutes. The webinar will cover the development of the chemical space, which currently consists of two phases. Phase 1 compounds were developed using various building block couplings that utilize more than 20 different types of reactions and no more than 2 synthetic steps. Phase 2 compounds were defined using novel WuXi scaffolds combined with in stock building blocks. Moreover, the webinar will demonstrate the use of the GalaXi space to access the chemical space and arrive at desirable hits.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on